Selenium-Enriched Akkermansia muciniphila: A Novel Probiotic Bacterium for Se Supplementation
- PMID: 40802225
- DOI: 10.1007/s12602-025-10713-0
Selenium-Enriched Akkermansia muciniphila: A Novel Probiotic Bacterium for Se Supplementation
Abstract
Selenium (Se)-enriched probiotics have gained widespread application in the fields of food, nutraceuticals, and biomedicine due to their capacity to deliver organic Se with high nutritional value to their hosts. Here, the inorganic Se bioconcentration was employed to generate Se-enriched Akkermansia muciniphila (Se-AM), and we investigated its Se distribution, selenoprotein and selenoamino acid species, essential elements, and amino acid contents. Furthermore, the major probiotic properties of Se-AM were evaluated. The results showed that the Se-AM exhibited remarkable survival and Se enrichment levels. The organic Se content in Se-AM accounted for approximately 81.9%, predominantly composed of protein bound Se (44.3%), followed by nucleic acid bound Se (17.8%) and polysaccharide bound Se (17.4%). The Se element in Se-AM exhibits a preference for binding to proteins with medium molecular weight, predominantly forming selenoamino acids containing SeCys2 and SeMet. Moreover, the content of both individual and total amino acids is higher in Se-AM compared to AM. Furthermore, Se-AM demonstrates robust acid resistance and antioxidant activity along with enhanced adhesion to Caco-2 and HT-29 cells. It also possesses immune-stimulating properties by activating the TLR4/NF-κB signaling pathway in Raw 264.7 cells, leading to increased cytokine release. Transcriptomic analysis reveals elevated expression levels of key genes associated with potent antioxidants, strong cellular adhesion capabilities, and effective cancer cell eradication within Se-AM when compared to AM. Our findings indicated that the Se-AM holds promising potential as a novel probiotic formulation supplemented with Se for both its Se-enhancing properties and probiotic functionality.
Keywords: Akkermansia muciniphila; Se nanoparticles (SeNPs); Selenium (Se)-enriched probiotics; Selenoamino acids; TLR4/NF-κB signaling pathway.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Akkermansia muciniphila-Derived Outer Membrane Vesicles as a Novel Therapeutic Approach for Mastitis: Insights From In Vitro and Vivo Studies.FASEB J. 2025 Jul 15;39(13):e70770. doi: 10.1096/fj.202500877RR. FASEB J. 2025. PMID: 40586785 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2014 Mar 30;2014(3):CD005195. doi: 10.1002/14651858.CD005195.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Jan 29;1:CD005195. doi: 10.1002/14651858.CD005195.pub4. PMID: 24683040 Free PMC article. Updated.
-
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9. Acc Chem Res. 2025. PMID: 40491030
-
Probiotics for management of functional abdominal pain disorders in children.Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD012849. doi: 10.1002/14651858.CD012849.pub2. Cochrane Database Syst Rev. 2023. PMID: 36799531 Free PMC article.
References
-
- Rayman MP (2012) Selenium and human health. Lancet 379(9822):1256–1268 - PubMed
-
- Yang J, Yang H (2021) Recent development in Se-enriched yeast, lactic acid bacteria and bifidobacteria. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2021.1948818 - DOI - PubMed
-
- Yang J et al (2018) Antibacterial activity of selenium-enriched lactic acid bacteria against common food-borne pathogens in vitro. J Dairy Sci 101(3):1930–1942 - PubMed
-
- Derrien M et al (2004) Akkermansia muciniphila gen. nov., sp nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54:1469–1476 - PubMed
Grants and funding
- No. 32200154/National Natural Science Foundation of China
- BJ23035/the Jiangsu Cadre health Care Research Project
- 0222E302/3456 Cultivation Program For Junior Talents of Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University
- 0224c043/High-Level Hospital Construction Project of Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University
LinkOut - more resources
Full Text Sources